An Israeli health official revealed on Sunday that Israel is currently in talks with several other countries over plans to redistribute some of its surplus stock of COVID-19 vaccines. The doses, developed by vaccine makers Pfizer and BioNTech, are due to expire by the end of the month.
Hezi Levi,...
Moderna shares gained 2.2% during premarket trading on Thursday as the biotech company reported a revenue of $570 million during the fourth quarter of 2020. This revenue surge came as a result of skyrocketing sales of the Massachusetts-based company's COVID-19 vaccine, mRNA-1273.
Despite this record-high sales revenue, the biotech firm...
Johnson & Johnson revealed recently that it has begun the process of seeking emergency use authorization of the booster shot for its COVID-19 vaccine for people 18 years of age and older. In order to embark on the process, the pharmaceutical giant submitted data to the U.S. Food and...
With Moderna (MRNA) stocks skyrocketing following the successful rollout of the company's COVID-19 vaccine, co-founder and chairman Noubar Afeyan has decided to sell a large portion of his shares totaling a value of approximately $1.4 billion.
From February 22nd through February 24th, Afeyan sold 6.5 million Moderna shares for a...
The Vietnamese health ministry reported on Wednesday that U.S. pharmaceutical company Pfizer would be providing 20 million doses of its COVID-19 vaccine to the Southeast Asian country. The vaccines, co-developed by German biotech company BioNTech, are expected to be administered to 12 to 18-year-olds as part of the next...
Johnson & Johnson's single-dose coronavirus shot recently received emergency use approval from the U.S. Food and Drug Administration on Saturday evening, making it the third COVID vaccine available for use in the United States.
Following the conclusion of early-phase clinical trials, the pharmaceutical giant submitted data regarding its results to...
Brain disease drug developer Neumora Therapeutics received a $100 million equity investment from U.S. biotech firm Amgen Inc. As a result, Neumora will receive global rights to produce and distribute some of Amgen's experimental drugs aimed at neurodegenerative diseases.
Together with the $400 million that the company raised from investors...
In an effort to make COVID-19 vaccines accessible to underprivileged Americans, Uber Technologies Inc, PayPal Holdings Inc, and Walgreens Inc confirmed on Monday that they will be launching a joint $11 million Vaccine Access Fund to provide free trips to coronavirus vaccination centers so that Americans who lack access...
Taiwanese company Pou Chen Corp halted operations at its plant in the Vietnamese capital of Ho Chih Minh City last wek as a result of COVID-19 concerns. The factory, which produces footwear for Nike and Adidas, took the decision as COVID-19 cases continue to surge in Vietnam's business hub.
Vietnam's...
After 33 years of operational difficulties, American vaccine development company Novavax has finally received approval for its COVID-19 vaccine shot. According to testing results, the Novavax vaccine has efficacy rates that are of a similar level to the vaccines developed by Pfizer and BioNTech as well as Moderna.
As the...